Cite
HARVARD Citation
Kavanaugh, A. et al. (n.d.). THU0432 Apremilast, An Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from 3 Phase III, Randomized, Controlled Trials. Annals of the rheumatic diseases. p. 346. [Online].